Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults - Results from the Rancho Bernardo Study

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

卷:52

Article

Daniels, Lori B.¹  Laughlin, Gail A.²  Clopton, Paul^1,3  Maisel, Alan S.^1,3  Barrett-Connor, Elizabeth² 

[1] Univ Calif San Diego, Dept Med, Div Cardiol, San Diego, CA 92103 USA

[2] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA

[3] Vet Affairs San Diego Healthcare Syst, La Jolla, CA USA

关键词: aging;    cardiovascular diseases;    epidemiology;    natriuretic peptides;    prognosis;    risk factors;    survival;   

DOI  :  10.1016/j.jacc.2008.04.033

来源: Elsevier

【 摘 要 】

Objectives This study investigated the prognostic value of detectable cardiac troponin T (TnT) and elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in a population of community-dwelling older adults. Background Minimally elevated levels of TnT, a marker of cardiomyocyte injury, have been found in small subsets of the general population, with uncertain implications. A marker of ventricular stretch, NT-proBNP has clinical utility in many venues, but its long-term prognostic value in apparently healthy older adults and in conjunction with TnT is unknown. Methods Participants were 957 older adults from the Rancho Bernardo Study with plasma NT-proBNP and TnT measured at baseline (1997 to 1999) and followed up for mortality through July 2006. Results Participants with detectable TnT (>= 0.01 ng/ ml, n = 39) had an increased risk of all-cause and cardiovascular death ( adjusted hazard ratio [HR] by Cox proportional hazards analysis: 2.06; 95% confidence interval [CI]: 1.29 to 3.28, p = 0.003 for all-cause mortality; HR: 2.06, 95% CI: 1.03 to 4.12, p = 0.040 for cardiovascular mortality); elevated NT-proBNP also predicted an increased risk of all-cause and cardiovascular mortality (adjusted HR per unit-log increase in NT-proBNP: 1.85, 95% CI: 1.36 to 2.52, p < 0.001 for all-cause mortality; HR: 2.51, 95% CI: 1.55 to 4.08, p < 0.001 for cardiovascular mortality). Those with both elevated NT-proBNP and detectable TnT had poorer survival (HR for high NT-proBNP and detectable TnT vs. low NT-proBNP and any TnT: 3.20, 95% CI: 1.91 to 5.38, p < 0.001). Exclusion of the 152 participants with heart disease at baseline did not materially change the TnT mortality or NT-proBNP mortality associations. Conclusions Apparently healthy adults with detectable TnT or elevated NT-proBNP levels are at increased risk of death. Those with both TnT and NT-proBNP elevations are at even higher risk, and the increased risk persists for years.

【 授权许可】

Free